Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Payables (2016 - 2025)

Macrogenics (MGNX) has disclosed Payables for 14 consecutive years, with $4.8 million as the latest value for Q4 2025.

  • Quarterly Payables fell 4.51% to $4.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.8 million through Dec 2025, down 4.51% year-over-year, with the annual reading at $4.8 million for FY2025, 4.51% down from the prior year.
  • Payables for Q4 2025 was $4.8 million at Macrogenics, down from $5.9 million in the prior quarter.
  • The five-year high for Payables was $15.5 million in Q4 2021, with the low at $2.6 million in Q2 2022.
  • Average Payables over 5 years is $6.2 million, with a median of $5.1 million recorded in 2024.
  • The sharpest move saw Payables surged 428.94% in 2021, then plummeted 73.43% in 2022.
  • Over 5 years, Payables stood at $15.5 million in 2021, then tumbled by 68.39% to $4.9 million in 2022, then soared by 31.52% to $6.4 million in 2023, then fell by 22.19% to $5.0 million in 2024, then decreased by 4.51% to $4.8 million in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $4.8 million, $5.9 million, and $4.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.